Pages that link to "Q44827392"
Jump to navigation
Jump to search
The following pages link to Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors (Q44827392):
Displaying 30 items.
- The significance of markers in the diagnosis of endometrial cancer (Q28067066) (← links)
- What Is the Best Preoperative Imaging for Endometrial Cancer? (Q28077761) (← links)
- FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features (Q28731816) (← links)
- Molecular cues on obesity signals, tumor markers and endometrial cancer. (Q30372789) (← links)
- A non-genetic route to aneuploidy in human cancers (Q30536313) (← links)
- Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy (Q33849248) (← links)
- Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer (Q34227653) (← links)
- Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor-positive early breast cancer in Canada (Q35445037) (← links)
- DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer (Q35603652) (← links)
- Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium (Q35909215) (← links)
- Biomarkers in endometrial cancer: Possible clinical applications (Review) (Q36084326) (← links)
- Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers (Q37081947) (← links)
- Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival (Q37706048) (← links)
- Biomarkers as prognostic factors in endometrial cancer (Q37808862) (← links)
- Markers for individualised therapy in endometrial carcinoma (Q38030768) (← links)
- Prognostic biomarkers in endometrial and ovarian carcinoma (Q38185940) (← links)
- Clinical value of DNA content assessment in endometrial cancer (Q38188485) (← links)
- Current status of molecular biomarkers in endometrial cancer (Q38234228) (← links)
- Microsatellite instability: an update (Q38363519) (← links)
- Genetic Instability and Disease Prognostication (Q38587988) (← links)
- LKB1 as a Tumor Suppressor in Uterine Cancer: Mouse Models and Translational Studies (Q39026772) (← links)
- A Selective Biomarker Panel Increases the Reproducibility and the Accuracy in Endometrial Biopsy Diagnosis. (Q39154480) (← links)
- Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study. (Q40784062) (← links)
- Genomic imbalances in endometrial adenocarcinomas - comparison of DNA ploidy, karyotyping and comparative genomic hybridization (Q41133781) (← links)
- The DNA index as a prognostic tool in hilar cholangiocarcinoma (Q41536162) (← links)
- Endometrial cancer (Q45164782) (← links)
- Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer (Q50926016) (← links)
- International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group. (Q52664780) (← links)
- Prognostic significance of DNA ploidy in stage I endometrial cancer (Q83863360) (← links)
- Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer (Q85076020) (← links)